DR. YANINA KOTLYAR MD NPI 1396717153

NPI Information

  • NPI: 1396717153
  • Provider Name: DR. YANINA KOTLYAR, MD
  • Classification: Internal Medicine - 207R00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • CLIA Number: 33D0983898
  • Address: 20 SQUADRON BLVD
    SUITE 550
    NEW CITY, NY
    ZIP 10956
  • Phone: (845) 634-8800

Map and Directions

Get Directions

NPI Details

DR. Yanina Kotlyar, MD is an internal medicine in New City, NY with 39 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Yanina Kotlyar, MD NPI is 1396717153. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

20 SQUADRON BLVD
SUITE 550
NEW CITY, NY
ZIP 10956-200
Phone: (845) 634-8800
Fax: (845) 638-1679

The NPI 1396717153 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 33D0983898 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Test for allergy using allergenic extract (HCPCS:95004)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Urinalysis, manual test (HCPCS:81002)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
  • Testing of autonomic nervous system function and heart rate response to deep breathing (HCPCS:95921)
  • Testing of autonomic (sympathetic) nervous system function (HCPCS:95923)
  • Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
  • Test to measure largest amount of air breathed in an out (HCPCS:94200)
  • Test for exercise-induced heart and lung stress (HCPCS:94621)
  • Evaluation of use of breathing device (HCPCS:94664)
  • Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
  • Test to examine how well the lungs exchange gases (HCPCS:94729)
  • Test to measure expiratory airflow and volume (HCPCS:94010)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Complete ultrasound study of arm and leg arteries (HCPCS:93923)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)

The enumeration date for this NPI number is 2/6/2006 and was last updated on 10/23/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine204324NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
116N701MEDICARE PINNEW YORK
2G39670MEDICARE UPINNEW YORK
301714167MEDICAIDNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.